# Nicotinamide Supplementation in Glaucoma

> **NCT06731582** · PHASE3 · ENROLLING_BY_INVITATION · sponsor: **Singapore Eye Research Institute** · enrollment: 520 (estimated)

## Conditions studied

- Glaucoma

## Interventions

- **DIETARY_SUPPLEMENT:** Nicotinamide Tablet
- **DIETARY_SUPPLEMENT:** Nicotinamide Placebo

## Key facts

- **NCT ID:** NCT06731582
- **Lead sponsor:** Singapore Eye Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-03-12
- **Primary completion:** 2027-07
- **Final completion:** 2028-07
- **Target enrollment:** 520 (ESTIMATED)
- **Last updated:** 2024-12-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06731582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06731582, "Nicotinamide Supplementation in Glaucoma". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06731582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*